LegalView Expands Its Extensive Traumatic Brain Injury Information Portal to Assist Victims of a Brain Injury Accident
LegalView re-launched its traumatic brain injury (TBI) information portal to provide a detailed and more comprehensive site for victims of TBI. In America, TBI affects millions of individuals each year, many of which go untreated and thus further their risk of serious side effects.
While the list of possible detrimental effects related to TBI seem to increase with each new TBI case, some of the more commonly known effects may include memory loss, inability to socialize or function normally, sensory loss, physical disability, coma and even death. However, treatment and medical research are available for a TBI victim and resources can be found on the newly launched TBI practice area from LegalView.
Individuals who have suffered a brain injury are encouraged to seek medical attention immediately and locate a brain injury law firm in their area. Because of the severity of the effects associated with a brain injury, it is important to be treated for TBI as well as to work with a brain injury attorney on the details related to any potential brain injury lawsuit. Medical bills associated with TBI are often extremely costly and can cause a victim to become financially overloaded, which is why developing TBI litigation can potentially ease the monetary burden that can accompany brain injury. Also, locating brain injury lawyers in a victim's area is made easier with the revamped TBI portal from LegalView.com.
In addition to the revamped TBI information portal, LegalView has also updated several practice areas recently to provide the best and most up-to-date information for victims of any type of injury, especially those associated with potential medical malpractice or pharmaceutical negligence. For example, new information on the Digitek digoxin risks and the Levaquin side effects has been updated on each drug's LegalView information portal, as well as the latest on the ongoing controversy over the potential Chantix recall.
Digitek digoxin is a prescription drug given to individuals suffering from irregular heart rhythm conditions such as congestive heart failure and arrhythmia. Recently, however, the Digitek risks became apparent to patients and medical professionals after a U.S. Food and Drug Administration (FDA) safety alert detailed the existence of potential double strength tablets that have "slipped" onto the market and may cause dangerous toxicity among individuals taking the drugs.
Similar to the Digitek controversy is that of Levaquin, which is an oral medication prescribed to patients suffering from infections, whether the infection is bronchitis, pneumonia or a skin infection, Levaquin is often the main anti-biotic treatment method. Patients of the drug have recently learned that there are some Levaquin side effects that may cause serious and long-term damage to an individual. One of the most serious side effects of the drug was tendon rupture, which may require an individual to undergo surgery.
Finally, LegalView continues to update readers on the Chantix controversy, which came to light in November 2007, after the FDA received hundreds of reports that the smoking cessation drug apparently increased the risk of suicidal thoughts and tendencies among patients. The Chantix side effects have allegedly been associated with nearly 40 patient suicides.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.